Immunovant Inc
Immunovant Inc (IMVT) Implied Volatility Current
IMVT implied volatility is 74%. IV Rank is 54%, placing current premiums in the middle of their 52-week range.
Read more
Tracking IMVT implied volatility helps you identify when options premiums on Immunovant Inc are historically cheap or expensive, and where the best trades are hiding. Immunovant Inc implied volatility reflects the market's expectation of future price movement: when IMVT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Immunovant Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMVT, tracking metrics like IMVT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMVT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMVT implied volatility sits today versus where it has been. Our scanner ranks Immunovant Inc implied volatility against its historical range, surfaces extremes in IMVT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Immunovant Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is slightly elevated - premiums are richer, leaning toward sellers.
As of September 17, 2026
Trade options with IV on your side
Track IMVT IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→